Diagnosis Test of Real-time Polymerase Chain Reaction (RT-PCR) for Pulmonary Tuberculosis
1 other identifier
observational
120
1 country
1
Brief Summary
BACKGROUND: Pulmonary tuberculosis remains the leading cause of morbidity and mortality in Thailand. The microbiological detection of TB is important because of early and correct diagnosis, drug resistance testing and ensures that the effective treatment can be achieved and in a timely manner. Mycobacterial culture is the gold standard diagnostic test. Currently, a real-time polymerase chain reaction (RT-PCR) assay, such as Allplex™ MTB/MDRe Detection, Seegene is commonly used. OBJECTIVE: To evaluate the diagnosis value of the real-time multiplex PCR by using Allplex™ MTB/MDRe Detection kit to detect MTB from sputum specimens with a gold standard TB culture.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedFirst Submitted
Initial submission to the registry
February 19, 2024
CompletedFirst Posted
Study publicly available on registry
February 28, 2024
CompletedFebruary 28, 2024
February 1, 2024
10 months
February 19, 2024
February 27, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of participants with pulmonary TB by Allplex™ MTB/MDRe
Laboratory parameter
From enrollment to the end of diagnosis at 1 week
Eligibility Criteria
out patients clinic
You may qualify if:
- Clinical suspected pulmonary M. tuberculosis infection
- Aged 15 years and older
You may not qualify if:
- Children under 15 years old
- Non-tuberculous mycobacteria (NTM) detection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Thananit Sangkomkamhang
Khon Kaen, 40000, Thailand
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kriengsak Vacharanukulkieti, Medicine
Khon Kaen Hospital
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of Hospital
Study Record Dates
First Submitted
February 19, 2024
First Posted
February 28, 2024
Study Start
January 1, 2023
Primary Completion
October 31, 2023
Study Completion
December 31, 2023
Last Updated
February 28, 2024
Record last verified: 2024-02